Discussion about this post

User's avatar
Man_In_PA's avatar

Is the problem that there is a new strain that evades the vaccines? Or is that the vaccine immunity loses potency with time? You think it's the former. I tend to believe it is the latter. Time will tell.

Expand full comment
David Watson's avatar

But the short answer to your title question is yes, they have a future. So does the stock, which is temporarily affected by current news but is more affected by long term prospects. Initial success, and anticipation of that success, boosted the stock. Failure of the current version will suppress it a little, but government obsession to try again will simple increase their future sales. Their marvelous technology can produce new versions quickly. MRNA is a definite buy.

And keep in mind they're not covid companies, or even vaccine companies. They're genetics companies with a broad stable of therapies for many illnesses already being developed. They're not perfect yet, but they're learning. Enhanced humans, both genetically and mechanically, are our inevitable future. Killing viruses is early innings of a long game.

Expand full comment
6 more comments...

No posts